MD Magazine (12/20, Rosenfeld) reported, “A motivational interviewing intervention did not initially drive at-risk adolescents to seek mental health treatment following an emergency department (ED) visit,” research indicated. Specifically, “adolescent patients who presented at the ED for nonpsychiatric concerns but screened positive for suicide risk did not significantly benefit from the Suicidal Teens Accessing Treatment After an Emergency Department Visit (STAT-ED) intervention,” the study revealed. The findings of the 168-patient randomized trial were published online Dec. 20 in JAMA Network Open.

Related Links:

— “Intervention Did Not Improve Adolescents Seeking Mental Healthcare, “Samara Rosenfeld, MD Magazine, December 20, 2019

HealthDay (12/19, Thompson) reports researchers found that “obesity in middle age is associated with an increased risk of dementia later in life” for women. In the study published in Neurology, the researchers found that women “who were obese in their mid-50s had 21% greater risk of being diagnosed with dementia 15 or more years later, compared with women who had a healthy weight.”

Related Links:

— “Obesity in Middle Age Could Raise Odds for Alzheimer’s Later, “Dennis Thompson, HealthDay, December 19, 2019

NBC News (12/19, Charles) reports on its website that the “suicide rate for black youth is rising faster than for any other racial and ethnic group, now making it the second-leading cause of death for black children aged 10 to 19, according to a congressional report released this week.” The 38-page report “was conducted by a task force of the Congressional Black Caucus and found a sharp rise in the rate of suicides and attempts among black youth.” It also “found that suicide attempts rose 73 percent from 1991 to 2017 for black adolescents of both sexes, and injuries from attempted suicides rose 122 percent for black boys in the same time period.”

Related Links:

— “Suicide rate rising fast for black youth, report finds, “Nick Charles, NBC News, December 19, 2019

Psychiatric News (12/19) reports, “Increasing the amount of green space around schools may lower the odds that children will exhibit attention-deficit/hyperactivity disorder” (AD/HD) symptoms, researchers concluded in a 59,754-child study. The findings were published online Dec. 18 in JAMA Network Open.

Related Links:

— “More Green Space Around Schools May Reduce ADHD Symptoms, Study Finds, Psychiatric News, December 19, 2019

Reuters (12/19, Rapaport) reports women with higher dietary glycemic index scores were more likely to have insomnia, according to a study published in the American Journal of Clinical Nutrition. The researchers examined “food diaries for more than 50,000 women in their mid-60s who had already gone through menopause” and found that “women with the highest dietary glycemic index scores – meaning they consumed more refined carbohydrates like white bread, sweets and sugary soda – were 11% more likely than women with the lowest scores to report insomnia at the start of the study period.” In addition, “they were also 16% more likely to develop new insomnia during the three-year follow-up period.”

Related Links:

— “Sugar and white bread tied to older women’s insomnia, “Lisa Rapaport, Reuters Health, December 19, 2019

The AP (12/19, Perrone) reports the FDA announced that gabapentin and pregabalin “can cause dangerous breathing problems when combined with opioids and certain other drugs.” The agency will “add new warnings to packaging for” the drugs, which “are among the most prescribed in the U.S.”

HealthDay (12/19) reports that “the new warnings” are “based on a review of data from numerous sources, including case reports, observational studies, human trials and animal studies.” While the two gabapentinoids are approved by the FDA for “epilepsy, postherpetic neuralgia (pain following shingles), neuropathic pain associated with diabetic neuropathy, fibromyalgia, generalized anxiety disorder and restless legs syndrome,” they are also commonly prescribed off-label for “insomnia, migraine, social phobia, panic disorder, mania, bipolar disorder and alcohol withdrawal.”

Medscape (12/19, Brooks, Subscription Publication) reports Dr. Douglas Throckmorton, an FDA official, said, “Reports of gabapentinoid abuse alone, and with opioids, have emerged and there are serious consequences of this co-use, including respiratory depression and increased risk of opioid overdose death.”

MedPage Today (12/19, George) also covers the story.

Related Links:

— “FDA warns of breathing risks with popular nerve drugs, “Matthew Perrone, AP, December 19, 2019

The AP (12/18, Johnson) discusses the effectiveness of buprenorphine as a treatment for opioid addiction and withdrawal, and its surprising lack of availability at addiction treatment centers across the country. As an example “in Missouri, some treatment programs had shunned buprenorphine, particularly long-term, in favor of abstinence-based counseling and support groups.” Also, “some believed medications were a crutch that prevented true recovery.” However, “in 2017, with overdose deaths rising, Missouri tied federal grant money to a medication-first philosophy.” As such, “programs would get money only if they started clients on meds rapidly and if they dropped rules about medication time limits and attending counseling.” As a result, “medication treatment increased and more patients stayed in treatment longer.” Despite these results and others, the addiction treatment field is still divided on the benefits of its use as a sustainable recovery method.

Related Links:

— “Walk-in clinics for opioid addiction offer meds first, fast, “Carla K. Johnson, AP, December 18, 2019

MD Magazine (12/18, Walter) reports that benzodiazepines, a class of medication used to treat anxiety, “may be misused and abused by children, leading to increased overdose and fatality rates,” researchers concluded after identifying and analyzing “national trends for pediatric benzodiazepine exposures between 2000-2015 after gathering data from 296,838 pediatric patients,” then procuring “data of benzodiazepine exposures in adolescences under the age of 18 who reported to participating US poison centers.” The findings were online Oct. 15 in the journal Clinical Toxicology.

Related Links:

— “Benzodiazepine Overdose Rates Increasing in Teens, “Kenny Walter, MD Magazine, December 18, 2019

Healio (12/18, Gramigna) reports, “Adolescent girls with anxiety disorders may be at an increased risk for eating disorders,” researchers concluded after analyzing “data for 2,406 female adolescents.” The findings of the “longitudinal cohort study” were published online Dec. 17 in the European Eating Disorders Review.

Related Links:

— “Study finds association between anxiety and eating disorders among adolescent girls, “Joe Gramigna, Healio, December 18, 2019

Healio (12/17, Gramigna) reports, “Black adolescents in the United States reported more than five instances of racial discrimination daily, which led to short-term increases in depressive symptoms,” researchers concluded after surveying “101 black U.S. American adolescents to measure daily racial discrimination and 14-day depressive symptoms slopes.” The findings were published in the January-February issue of the Journal of Applied Developmental Psychology.

Related Links:

— “Black adolescents may experience five daily instances of racial discrimination, “Joe Gramigna, Healio, December 17, 2019